Latest Carotid stenting Stories
The New CGuard(TM) RX Rapid Exchange System Receives CE Mark Approval BOSTON, Jan.
CGuardTM All Comer Data Continues to Show Excellent Clinical Benefits of the MicroNetTM Covered Technology BOSTON, Jan.
Near-term Focus On Carotid and DES Products, Streamlined Operations BOSTON, Jan.
MASTER I and MASTER II Pooled Data Show Statistically Significant Mortality Benefit BOSTON, Dec.
30 Day Stroke Rate of 1.4% Highlights Excellent Neuroprotection with Novel Hybrid Procedure for Carotid Artery Revascularization SUNNYVALE, Calif., Nov.
MALVERN, Pa., Oct.
LEXINGTON, Ky., Sept.
A new issue of the Journal of Endovascular Therapy features a study showing favorable results for self-expanding nitinol stents compared with balloon angioplasty for treatment of superficial femoral
Imaging can be a cost-effective way to identify people at risk for stroke who might benefit from aggressive intervention, according to a new modeling study published online, September 16, in the
SUNNYVALE, Calif., July 23, 2014 /PRNewswire/ -- Silk Road Medical, Inc., a developer of advanced devices for the transcarotid treatment of intra- and extra-cranial cerebrovascular disease,
- A poem in which the author retracts something said in an earlier poem.